TEC
MDT icon

Tiger Eye Capital’s Medtronic MDT Stock Holding History

Tiger Eye Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-170,213
Closed -$14.8M – 44
2016
Q2 		$14.8M Buy
+170,213
New +$13.8M 2.08% 25

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Tiger Eye Capital's MDT Position: Q3 2016 in Review

Tiger Eye Capital sold out of Medtronic (MDT) in Q3 2016, closing a stake of 170,213 shares — an estimated $14.8M sold.

Tiger Eye Capital first reported a position in MDT in Q2 2016 and held it in 1 quarter. The position peaked at $14.8M in Q2 2016. 1,266 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • Tiger Eye Capital reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
  • Tiger Eye Capital sold 170,213 Medtronic shares in Q3 2016, an estimated $14.8M.
  • Tiger Eye Capital first reported a position in Medtronic in Q2 2016 and held it in 1 quarter.
  • Tiger Eye Capital's Medtronic position peaked at $14.8M in Q2 2016.
  • 1,266 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Tiger Eye Capital's 13F filing for Q3 2016, filed 10 Nov 2016.